BACKGROUND: The best treatment options for walled-off pancreatic necrosis (WOPN) are not well defined. A retrospective study of patients treated for WOPN with transgastric debridement and internal drainage was undertaken. METHODS: Patients with symptomatic non-infected WOPN treated with open transgastric debridement and internal drainage were evaluated. RESULTS: In all, 51 patients underwent surgical management of necrotizing pancreatitis during the study period. Ten patients (19%) were treated with open transgastric debridement and internal drainage for symptomatic non-infected WOPN. The median patient age was 40 years, the most common aetiology for pancreatitis was biliary, the mean American Society of Anesthesiologists (ASA) score was 2 and the delay to surgery was 100 days. The operating time was 118 min, with a blood loss of 50cc. One patient required reoperation, three patients had morbidity and there were no mortalities. The only factor associated with post-operative morbidity was the presence of positive cultures (P < 0.05). The length of stay (LOS) after surgery was 8 days, at a median follow-up of 18 months, one patient had late complications related to the surgery and the procedure was successful in 90% of the patients. DISCUSSION: Open transgastric debridement with internal drainage of WOPN is safe and efficacious. Patients were clinically stable (no organ failure) and had a long delay in surgical intervention (100 days). In this select group of patients, the success, morbidity and mortality is similar to all reported minimally invasive techniques.
BACKGROUND: The best treatment options for walled-off pancreatic necrosis (WOPN) are not well defined. A retrospective study of patients treated for WOPN with transgastric debridement and internal drainage was undertaken. METHODS:Patients with symptomatic non-infected WOPN treated with open transgastric debridement and internal drainage were evaluated. RESULTS: In all, 51 patients underwent surgical management of necrotizing pancreatitis during the study period. Ten patients (19%) were treated with open transgastric debridement and internal drainage for symptomatic non-infected WOPN. The median patient age was 40 years, the most common aetiology for pancreatitis was biliary, the mean American Society of Anesthesiologists (ASA) score was 2 and the delay to surgery was 100 days. The operating time was 118 min, with a blood loss of 50cc. One patient required reoperation, three patients had morbidity and there were no mortalities. The only factor associated with post-operative morbidity was the presence of positive cultures (P < 0.05). The length of stay (LOS) after surgery was 8 days, at a median follow-up of 18 months, one patient had late complications related to the surgery and the procedure was successful in 90% of the patients. DISCUSSION: Open transgastric debridement with internal drainage of WOPN is safe and efficacious. Patients were clinically stable (no organ failure) and had a long delay in surgical intervention (100 days). In this select group of patients, the success, morbidity and mortality is similar to all reported minimally invasive techniques.
Authors: Hjalmar C van Santvoort; Marc G Besselink; Olaf J Bakker; H Sijbrand Hofker; Marja A Boermeester; Cornelis H Dejong; Harry van Goor; Alexander F Schaapherder; Casper H van Eijck; Thomas L Bollen; Bert van Ramshorst; Vincent B Nieuwenhuijs; Robin Timmer; Johan S Laméris; Philip M Kruyt; Eric R Manusama; Erwin van der Harst; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Maarten S van Leeuwen; Erik Buskens; Hein G Gooszen Journal: N Engl J Med Date: 2010-04-22 Impact factor: 91.245
Authors: T L Bollen; H C van Santvoort; M G Besselink; M S van Leeuwen; K D Horvath; P C Freeny; H G Gooszen Journal: Br J Surg Date: 2008-01 Impact factor: 6.939
Authors: J Ruben Rodriguez; A Oswaldo Razo; Javier Targarona; Sarah P Thayer; David W Rattner; Andrew L Warshaw; Carlos Fernández-del Castillo Journal: Ann Surg Date: 2008-02 Impact factor: 12.969
Authors: S Connor; P Ghaneh; M Raraty; R Sutton; E Rosso; C J Garvey; M L Hughes; J C Evans; P Rowlands; J P Neoptolemos Journal: Dig Surg Date: 2003-05-15 Impact factor: 2.588
Authors: Rogier P Voermans; Mariëlle C Veldkamp; Erik A Rauws; Marco J Bruno; Paul Fockens Journal: Gastrointest Endosc Date: 2007-11 Impact factor: 9.427
Authors: Eric S Hungness; Bruce W Robb; Connie Seeskin; Per-Olof Hasselgren; Fred A Luchette Journal: J Am Coll Surg Date: 2002-06 Impact factor: 6.113
Authors: Timothy B Gardner; Prabhleen Chahal; Georgios I Papachristou; Santhi Swaroop Vege; Bret T Petersen; Christopher J Gostout; Mark D Topazian; Naoki Takahashi; Michael G Sarr; Todd H Baron Journal: Gastrointest Endosc Date: 2009-02-24 Impact factor: 9.427
Authors: Mohammad Khreiss; Mazen Zenati; Amber Clifford; Kenneth K Lee; Melissa E Hogg; Adam Slivka; Jennifer Chennat; Andres Gelrud; Herbert J Zeh; Georgios I Papachristou; Amer H Zureikat Journal: J Gastrointest Surg Date: 2015-06-02 Impact factor: 3.452
Authors: Kerri A Simo; David J Niemeyer; Ryan Z Swan; David Sindram; John B Martinie; David A Iannitti Journal: Surg Endosc Date: 2014-03-27 Impact factor: 4.584
Authors: Thomas K Maatman; Sean P McGuire; Katelyn F Flick; Mackenzie K Madison; Mohammad A Al-Haddad; Benjamin L Bick; Eugene P Ceppa; John M DeWitt; Jeffrey J Easler; Evan L Fogel; Mark A Gromski; Michael G House; Glen A Lehman; Attila Nakeeb; C Max Schmidt; Stuart Sherman; James L Watkins; Nicholas J Zyromski Journal: Ann Surg Date: 2021-09-01 Impact factor: 13.787